Latest Articles
- ArticleMOG cell-based assay detects non-MS patients with inflammatory neurologic diseasePatrick Waters, Mark Woodhall, Kevin C. O'Connor, et al.March 19, 2015
- Clinical/Scientific NotesA 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodiesKatrina A. Morris, Paddy Waters, Mark R. Woodhall, et al.March 19, 2015
- EditorialIs intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?Martin S. WeberMarch 12, 2015
- ArticleMyelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in childrenYael Hacohen, Michael Absoud, Kumaran Deiva, et al.March 12, 2015
- Clinical/Scientific NotesPontine myelinolysis following excessive consumption of commercial energy drinksBraeden D. Newton, Darin T. OkudaMarch 12, 2015
- Clinical/Scientific NotesEncephalomyeloneuropathy with CRMP-5 antibodies in a patient with a primary mediastinal serinomaCliff W. Hampton, Dina Galperin, Enrique Alvarez, et al.March 12, 2015
- Clinical/Scientific NotesNeuromyelitis optica phenotype associated with therapy-responsive acute peripheral neuropathyAnteneh M. Feyissa, Elena Shanina, Rahul Shah, et al.March 12, 2015
- ArticlePreclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MSHeather B. Streeter, Rachel Rigden, Keith F. Martin, et al.March 12, 2015
- Clinical/Scientific NotesProgressive multifocal leukoencephalopathy during fumarate monotherapy of psoriasisRobert Hoepner, Simon Faissner, Anja Klasing, et al.March 12, 2015
Pages
Advertisement